This document is about the diagnosis and treatment guidelines for HIV-infected pregnancy, including the definition, epidemiology, pathophysiology, clinical manifestations, diagnosis, treatment and prognosis of HIV-infected pregnancy.
This document is a Japanese clinical guideline for the care of HIV-infected pregnant women and the prevention of mother-to-child transmission. It states that its purpose is to maintain a standard level of HIV mother-to-child infection prevention among facilities and medical providers in Japan, and that it is based on information as of August 2020. It was issued as the second edition in March 2021 under a Ministry of Health, Labour and Welfare research project.
Its contents include the current status of HIV-infected pregnancy, pregnancy screening, antiretroviral therapy during pregnancy, co-infections, perinatal management, infant care, unattended pregnant women, postpartum care, and pregnancy in HIV-infected women. The guideline uses recommendation levels A, B, and C, and states that final treatment decisions should be made case by case according to the patient's condition and pregnancy course. This manual is written in Japanese.
Its purpose is to maintain a standard level of HIV mother-to-child infection prevention among facilities and medical providers in Japan.
It is written based on information as of August 2020.
Level A means randomized controlled trial literature exists and performing the action is strongly recommended.
This edition was published in March 2021.